Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Cerebral Malaria

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Cerebral Malaria in 1 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Research Excerpts

ExcerptRelevanceReference
"The pathology of cerebral malaria is considered to be primarily immunological."5.36Modulation of cerebral malaria by fasudil and other immune-modifying compounds. ( Ginsburg, H; Golenser, J; Hunt, N; McQuillan, JA; Waknine-Grinberg, JH, 2010)
"The pathology of cerebral malaria is considered to be primarily immunological."1.36Modulation of cerebral malaria by fasudil and other immune-modifying compounds. ( Ginsburg, H; Golenser, J; Hunt, N; McQuillan, JA; Waknine-Grinberg, JH, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Waknine-Grinberg, JH1
McQuillan, JA1
Hunt, N1
Ginsburg, H1
Golenser, J1

Other Studies

1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Cerebral Malaria

ArticleYear
Modulation of cerebral malaria by fasudil and other immune-modifying compounds.
    Experimental parasitology, 2010, Volume: 125, Issue:2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Curcumin; Disease Models, Animal; Enzyme Inh

2010